Learn More
7536 Background: We assessed the impact of gene polymorphisms on clinical outcome in advanced non-small cell lung cancer (NSCLC) patients receiving platinum-gemcitabine chemotherapy (PG). METHODS(More)
INTRODUCTION In this study we evaluated the value of pre-operative glucose corrected maximum standard uptake value (GC-SUVmax) as prognostic factor in patients with early stage non-small cell lung(More)